| Dr Dale Michael Schaefer, MD | |
|
1300 28th St S, Suite 7, Great Falls, MT 59405-5296 | |
| (406) 454-0375 | |
| (406) 454-0377 |
| Full Name | Dr Dale Michael Schaefer |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 40 Years |
| Location | 1300 28th St S, Great Falls, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609951631 | NPI | - | NPPES |
| 0000089726 | Medicaid | MT | |
| 1711 | Other | MT | BC/BS OF MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 6855 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Benefis Hospitals Inc | Great falls, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Benefis Hospitals Inc | 1153235296 | 279 |
News Archive
Patients with schizophrenia who take antipsychotic medications appear to lose a small but measurable amount of brain tissue over time, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Deep brain stimulation (DBS) in a precise region of the brain appears to reduce caloric intake and prompt weight loss in obese animal models, according to a new study led by researchers at the University of Pennsylvania.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
Scientists are a step closer to understanding what controls fine particulate matter in the Earth's atmosphere after identifying new linkages between natural contaminants and with manmade pollutants.
› Verified 5 days ago
| Entity Name | Benefis Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780968974 PECOS PAC ID: 1153235296 Enrollment ID: O20100629000044 |
News Archive
Patients with schizophrenia who take antipsychotic medications appear to lose a small but measurable amount of brain tissue over time, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Deep brain stimulation (DBS) in a precise region of the brain appears to reduce caloric intake and prompt weight loss in obese animal models, according to a new study led by researchers at the University of Pennsylvania.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
Scientists are a step closer to understanding what controls fine particulate matter in the Earth's atmosphere after identifying new linkages between natural contaminants and with manmade pollutants.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dale Michael Schaefer, MD 1300 28th St S, Suite 7, Great Falls, MT 59405-5296 Ph: (406) 454-0375 | Dr Dale Michael Schaefer, MD 1300 28th St S, Suite 7, Great Falls, MT 59405-5296 Ph: (406) 454-0375 |
News Archive
Patients with schizophrenia who take antipsychotic medications appear to lose a small but measurable amount of brain tissue over time, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Deep brain stimulation (DBS) in a precise region of the brain appears to reduce caloric intake and prompt weight loss in obese animal models, according to a new study led by researchers at the University of Pennsylvania.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
Scientists are a step closer to understanding what controls fine particulate matter in the Earth's atmosphere after identifying new linkages between natural contaminants and with manmade pollutants.
› Verified 5 days ago
Kristin Huntoon, D.O, PHD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-455-5000 Fax: 406-731-8318 | |
John G Van Gilder, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 15th Ave S, 101, Great Falls, MT 59405 Phone: 406-452-9504 Fax: 406-761-3192 | |
Paul L Gorsuch Jr., MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 401 15th Ave S, #101, Great Falls, MT 59405 Phone: 406-761-3181 Fax: 406-761-3192 | |
Benny Earl Brandvold, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-455-5000 Fax: 406-731-8318 | |
Richard J Teff, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-731-8888 Fax: 406-731-8318 |